Your browser doesn't support javascript.
loading
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years.
Sheth, Vipul Sharad; Potter, Victoria; Gandhi, Shreyans A; Kulasekararaj, Austin Gladston; de Lavallade, Hugues; Muus, Petra; Pagliuca, Antonio; Rice, Carmel F M; Mehra, Varun; Grimaldi, Francesco; Inam, Shafqat; Barber, Linda D; Mufti, Ghulam J; Marsh, Judith C.
Afiliação
  • Sheth VS; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Potter V; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Gandhi SA; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Kulasekararaj AG; Department of Haematological Medicine, King's College London, London, United Kingdom; and.
  • de Lavallade H; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Muus P; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Pagliuca A; Department of Haematological Medicine, King's College London, London, United Kingdom; and.
  • Rice CFM; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Mehra V; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Grimaldi F; Department of Haematological Medicine, King's College London, London, United Kingdom; and.
  • Inam S; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Barber LD; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Mufti GJ; Department of Haematological Medicine, King's College London, London, United Kingdom; and.
  • Marsh JC; Department of Hematology, Federico III University of Naples, Naples, Italy.
Blood Adv ; 3(20): 3070-3079, 2019 10 22.
Article em En | MEDLINE | ID: mdl-31648330

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Alemtuzumab / Antineoplásicos Imunológicos / Anemia Aplástica Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Alemtuzumab / Antineoplásicos Imunológicos / Anemia Aplástica Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article